RxNorm 1806926 NDC Crossover
PANCREAZE 16,800 UNT / 98,400 UNT / 56,800 UNT Delayed Release Oral Capsule
Related NDC Codes to RxNorm Concept 1806926
The following NDC codes crossover to the RxNorm Concept 1806926. This list is useful when crossing over from a given RxNorm code and the user is trying to choose a drug or product included in the NDC directory.
| NDC | Proprietary Name | Non-Proprietary Name | Dosage Form | Route Name | Labeler Name | Status | |
|---|---|---|---|---|---|---|---|
| 62541-401 | Pancreaze | Pancrelipase Lipase, Pancrelipase Amylase, And Pancrelipase Protease | Capsule, Delayed Release | Oral | Vivus Llc | ACTIVE | |
| 62541-402 | Pancreaze | Pancrelipase Lipase, Pancrelipase Amylase, And Pancrelipase Protease | Capsule, Delayed Release | Oral | Vivus Llc | ACTIVE | |
| 62541-403 | Pancreaze | Pancrelipase Lipase, Pancrelipase Amylase, And Pancrelipase Protease | Capsule, Delayed Release | Oral | Vivus Llc | ACTIVE | |
| 62541-404 | Pancreaze | Pancrelipase Lipase, Pancrelipase Amylase, And Pancrelipase Protease | Capsule, Delayed Release | Oral | Vivus Llc | ACTIVE | |
| 62541-405 | Pancreaze | Pancrelipase Lipase, Pancrelipase Amylase, And Pancrelipase Protease | Capsule, Delayed Release | Oral | Vivus Llc | ACTIVE | |
| 62541-406 | Pancreaze | Pancrelipase Lipase, Pancrelipase Amylase, And Pancrelipase Protease | Capsule, Delayed Release | Oral | Vivus Llc | ACTIVE |
